Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
[google_news title=”” keyword=”Detect Early Lung Cancer” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Detect Early Lung Cancer
- Center offers state-of-the-art early diagnosis and treatment for lung canceron April 17, 2024 at 4:05 pm
► Get breaking news from your neighborhood delivered directly to you by downloading the new FREE WWL-TV News app now in the IOS App Store or Google Play.
- Stopping Lung Cancer Before It Progresseson April 17, 2024 at 9:05 am
Lung cancer is still the leading cause of death by cancer in the U.S., with someone diagnosed about every two minutes.
- Lung cancer screenings to be offered at OU Health Stephenson Cancer Centeron April 16, 2024 at 5:01 pm
OKLAHOMA CITY – To promote early cancer detection and provide lifesaving resources to the community, OU Health Stephenson Cancer Center at the University of Oklahoma Health Sciences (800 NE 10th St, ...
- Only 3% of eligible Marylanders are screened for lung cancer. A new partnership aims to change that.on April 16, 2024 at 3:25 pm
Lung cancer is by far the leading cause of cancer deaths in America. Each year, it accounts for roughly 1 in 5 cancer deaths, killing more than colon, breast and prostate cancers combined. However, ...
- Breakthrough blood tests open new frontiers in cancer detectionon April 16, 2024 at 3:20 pm
A series of cutting-edge blood tests have ignited excitement among cancer specialists, promising a new era in oncology by detecting malignancies that previously went unnoticed until they reached ...
- A blood test to detect cancer? Some patients are using them already.on April 16, 2024 at 3:30 am
New blood tests measure “signals” in the blood to help detect cancer. Experts say more study is needed to determine if the new tests save lives.
- Few Marylanders are screened for lung cancer. Can this new $8M statewide effort change that?on April 15, 2024 at 11:15 pm
A recently announced University of Maryland partnership aims to enhance cancer screening and early detection, leading to earlier diagnoses and more treatment options.
- Lifesaving tech: Lung cancer caught early with AI assist at Tavares' AdventHealth Watermanon April 12, 2024 at 1:29 pm
Too often lung cancer and late-stage diagnoses are the norm. A new procedure available at AdventHealth Waterman aims to detect it sooner by using AI.
- Early Detection Of Lung Cancer In Older Smokers Appears More Effective Than Quittingon April 9, 2024 at 10:50 am
Early detection of lung cancer in older smokers appears to be more effective than quitting. Earlier diagnosis via CT scan offers a better chance that treatment will work.
- ‘Saved by the scan’: Lung cancer survivor advocates for early detection, research fundingon April 9, 2024 at 1:04 am
The “Saved by the Scan” campaign started in 2017, offering a lung cancer screening test and an eligibility quiz. Screening is used to detect lung cancer. Research suggests when diagnosed at an early ...
via Bing News